Fullerenol Inhibits Tendinopathy by Alleviating Inflammation
Overview
Affiliations
Tendinopathy is a common disease in orthopaedics, seriously affecting tendon functions. However, the effects of non-surgical treatment on tendinopathy are not satisfactory and surgical treatments possibly impair the function of tendons. Biomaterial fullerenol has been proved to show good anti-inflammatory effects on various inflammatory diseases. For experiments, primary rat tendon cells (TCs) were treated by interleukin-1 beta (IL-1β) combined with aqueous fullerenol (5, 1, 0.3 μg/mL). Then inflammatory factors, tendon-related markers, migration and signaling pathways were detected. For experiments, rat tendinopathy model was constructed by local injection of collagenase into Achilles tendons of rats and fullerenol (0.5, 1 mg/mL) was locally injected 7 days after collagenase injection. Inflammatory factors and tendon-related markers were also investigated. Fullerenol with good water-solubility showed excellent biocompatibility with TCs. Fullerenol could increase expression of tendon-related factors (Collagen I and tenascin C) and decrease expression of inflammatory factors (matrix metalloproteinases-3, MMP-3, and MMP-13) and reactive oxygen species (ROS) level. Simultaneously, fullerenol slowed the migration of TCs and inhibited activation of Mitogen-activated protein kinase (MAPK) signaling pathway. Fullerenol also attenuated tendinopathy , including reduction of fiber disorders, decrease of inflammatory factors and increase of tendon markers. In summary, fullerenol is a promising biomaterial that can be used to treat tendinopathy.
Treatment options for Achilles tendinopathy: a scoping review of preclinical studies.
Agyeman-Prempeh N, Maas H, Burchell G, Millar N, Moen M, Smit T PeerJ. 2025; 13():e18143.
PMID: 39807157 PMC: 11727660. DOI: 10.7717/peerj.18143.
Sosnowska M, Wierzbicki M, Nasilowska B, Bakalova T, Piotrowska K, Strojny-Cieslak B Int J Nanomedicine. 2024; 19:12221-12255.
PMID: 39600409 PMC: 11588572. DOI: 10.2147/IJN.S482652.
Wang Z, Dong Z, Li Y, Jiao X, Liu Y, Chang H Biomedicines. 2024; 12(4).
PMID: 38672259 PMC: 11048132. DOI: 10.3390/biomedicines12040904.